Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines

The development of immunity to vaccine antigen was examined using three prime/boost strategies and the progression of immune activities was evaluated over the course of 8 weeks. Calves were vaccinated and multiple immune parameters were evaluated using several methods to assess humoral or cellular immunity from the same samples in parallel. The three vaccination protocols used were a killed vaccine followed by a killed boost (killed/killed), MLV vaccine and boost (MLV/MLV), or a MLV vaccine and killed boost (MLV/killed). All the vaccines used included modified live IBR/PI3 viruses to make the bystander context as similar as possible. The Singer strain of BVDV was used as the source antigen in the killed vaccine, and the NADL strain of BVDV was used in the MLV vaccine. Controls received a vaccine containing only MLV IBR/PI3. The assessment panel measured SN titers, as well as lymphocyte proliferation, cytokine mRNA expression, intracellular cytokine production, and released IFN-gamma after in vitro stimulation with three strains of BVDV virus. MLV/MLV and MLV/killed groups developed significant SN titers to the type 1 BVDV virus strains, Singer and NADL, and low crossover titers were also seen to the type 2 strain, 890 over the evaluation period. These two groups showed significant proliferation in response to the NADL virus as compared to controls. Multiple immune assessments were conducted simultaneously to attempt to provide a broader, more in depth evaluation of immune response to these BVDV vaccination protocols. We observed that the correlation among most of the assays conducted were weak; the correlation between SN titers and cellular proliferation assays demonstrated a moderate correlation.     

吉林某牛场牛病毒性腹泻流行病学调查及分析

为全面了解吉林省某规模化牛场牛病毒性腹泻(BVD)的流行情况,试验采集临床血清样品157份,粪便样品18份,肝脏、精液等组织样品17份,应用BVDV抗体检测试剂盒进行血清抗体检测,利用BVDV1型引物,采用纳米PCR方法对血清及临床样品进行BVDV抗原检测,对抗原阳性样品进行测序分析;将抗原阳性样品经研磨、稀释后用0.22μm滤膜过滤除菌,接入牛肾细胞(MDBK)进行病毒分离培养,盲传3代后再次进行抗原检测;采用免疫荧光技术检测病毒对MDBK细胞的侵染作用;利用Mega软件绘制系统进化树并进行同源性比对分析。结果显示,该牛场临床血清BVDV抗体阳性率为77.1%,血清抗原阳性率为12.1%,临床粪便等样品抗原阳性率为74.3%;病料接入细胞未观察到细胞病变,分离毒株PCR产物测序分析结果与样品抗原检测结果一致;免疫荧光检测结果显示,分离株毒液正常吸附于MDBK细胞中,有明显荧光反应;抗原测序分析显示,该牛场BVD主要流行毒株与BVDV JL-1株同源性高达99.0%,且均为BVDV 1型毒株。本研究对该牛场BVDV流行情况进行了全面调查,为开展净化工作奠定了基础。     

胎牛血清中牛病毒性腹泻病毒2型毒株分离及脱脂奶粉中抗体的检测

本研究旨在对进口胎牛血清中的牛病毒性腹泻病毒（BVDV）进行分离及鉴定。利用BVDV抗原和抗体检测试剂盒检测,提取胎牛血清中的病毒RNA,用5'-UTR巢式PCR进行扩增,PCR扩增产物连接pMD19-T进行测序分析。胎牛血清样品接种MDBK细胞,进行细胞传代培养,通过细胞分离培养、直接免疫荧光抗体检测对实验室进口胎牛血清样品进行病毒分离及鉴定,应用DNAStar对BVDV 5'-UTR、N^pro与GenBank中公布的瘟病毒参考株进行多序列比对,采用Mega 6.0进行遗传进化分析。同时通过包被脱脂奶粉进行间接ELISA检测其中的BVDV抗体。结果显示,胎牛血清中BVDV抗原和抗体均为阳性,并且从胎牛血清中成功分离到一株新的牛源BVDV,命名为BVDV-GC株,该病毒株在MDBK细胞上进行增殖培养时未能引起细胞病变;5'-UTR与N^pro PCR扩增为阳性,扩增产物大小均与预期相符;直接免疫荧光检测荧光信号为阳性;病毒滴度为10^-3.6TCID₅₀/0.1 mL;遗传进化分析表明,该分离株与USMARC-60779（BVDV-2）株有较近的亲缘关系,同属于BVDV-2型毒株;通过包被脱脂奶粉和商品化的ELISA试剂盒进行检测,结果表明脱脂奶粉中存在BVDV抗体。本研究从进口胎牛血清中分离出1株BVDV-2型非致细胞病变病毒,从脱脂奶粉中检测到BVDV抗体,表明进口胎牛血清和脱脂奶粉中都存在BVDV抗原和抗体污染,本研究为后续试验分析提供参考。     

Monitoring bovine viral diarrhea virus vaccines for adventitious virus, using T1 ribonuclease viral RNA oligonucleotide fingerprinting.

Viral RNA oligonucleotide fingerprinting was used to discriminate 3 cytopathic vaccine bovine viral diarrhea viruses (BVDV) grown in medium supplemented with serum contaminated with noncytopathic BVDV from the same 3 viruses grown in cell culture free of BVDV. Oligonucleotide fingerprinting also effectively discriminated between reference Singer BVDV, NADL BVDV, and New York-1 BVDV grown in BVDV-free noncontaminated or BVDV-contaminated cell cultures. Oligonucleotide fingerprint mapping of viral RNA maybe used to determine the purity of virus stocks, as well as that of BVDV vaccines.     

CHO细胞表达牛病毒性腹泻病毒E2蛋白及免疫原性分析

旨在利用悬浮培养CHO细胞表达系统制备牛病毒性腹泻病毒(bovine viral diarrhea virus,BVDV) E2蛋白,并鉴定纯化E2蛋白的免疫原性。本研究以BVDV-1 NADL株基因序列为基础,构建BVDV E2蛋白的重组真核表达质粒pcDNA3.1-BVDV-E2,转染经悬浮培养的CHO细胞进行分泌表达,收集细胞培养上清,进行亲和层析法纯化,SDS-PAGE电泳鉴定蛋白表达和纯化,Western blot鉴定与His抗体和BVDV阳性血清反应性,利用纯化蛋白免疫新西兰大白兔,用细胞间接免疫荧光(IFA)和ELISA鉴定E2蛋白的反应活性。纯化E2蛋白经BCA蛋白定量试剂盒检测后表达量高达1.228 mg·mL^-1;Western blot结果显示,利用His抗体和BVDV阳性血清均可检测到目的蛋白的特异性条带;新西兰大白兔一免后第7天利用间接ELISA可检测到血清抗体阳性,并持续至免疫后第28天,血清抗体效价水平达到1∶1 024 000;IFA试验结果显示,该血清抗体可检测到BVDV感染MDBK细胞中E2蛋白的表达,进一步证实纯化的E2蛋白具有良好的免疫原性和特异性。本研究成功利用CHO悬浮培养真核表达系统制备了纯化的BVDV E2蛋白,该蛋白具有良好的免疫原性,为BVDV的诊断方法及其新型亚单位疫苗研制奠定了基础。     

Comparison of humoral immune responses in dairy heifers vaccinated with 3 different commercial vaccines against bovine viral diarrhea virus and bovine herpesvirus-1

A randomized clinical trial was conducted to compare the humoral immune response to 3 different commercial vaccines in dairy heifers housed in 3 different dairy farms in Quebec. All heifers were seronegative to type 1 bovine viral diarrhea virus (BVDV) (Singer strain), type 2 BVDV (NVSL 125c strain), and bovine herpesvirus-1 (BHV-1) at the beginning of the trial. In addition, control heifers in group 1 remained seronegative to the 2 viruses till the end of the trial. Significant differences in humoral immune responses occurred among the 3 commercial vaccines at 4 weeks and 6 months following vaccination. The vaccine in group 2 elicited higher mean antibody titers and seroconversion rates to both type 1 and type 2 BVDV than that in groups 3 or 4. Vaccines in groups 2 and 3 induced higher mean antibody titers to BHV-1 than did the vaccine in group 4.     

Natural infection of pigs with bovine viral diarrhea virus and its differential diagnosis from hog cholera.

Natural infection of pigs with bovine viral diarrhea virus (BVDV) through contact with infected cattle has caused problems in diagnosing hog cholera (HC). Low cross-reacting serum antibody titers against HC caused by BVDV infection were found in clinically normal pigs as well as those suspected of having HC. Bovine viral diarrhea virus was isolated from specimen tissues and initially identified as HC virus (HCV), using the fluorescent antibody cell culture technique. Additional cell cultures, as well as pig and calf trials, were necessary to identify it as BVDV. The isolate caused clinical signs of illness in the calves, whereas the pigs remained healthy. Bovine viral diarrhea virus may be detected in tissue sections or isolated in cell cultures and confirmed as HCV, using the HC fluorescent antibody conjugate. Laboratories performing the neutralization test for HC should use discretion when interpreting HC titers unless BVD titers are determined on the same serums.     

牛病毒性腹泻弱毒活疫苗免疫持续期的研究

为检测牛病毒性腹泻病毒(BVDV)弱毒活疫苗在免疫牛体内抗体产生及其消长规律,评价弱毒疫苗的保护效力,并确定免疫持续期,本试验对免疫试验牛每头颈部肌肉接种BVDV SM株弱毒疫苗10^4.5TCID₅₀/头,监测血清抗体效价,进行免疫持续期的确定。在疫苗免疫后的6、9和12个月分别抽取5头免疫组和5头对照组牛采用BVDV-JL强毒株进行攻毒试验,每头牛攻毒剂量为6×10^7.0 TCID₅₀/mL。结果显示疫苗免疫后12个月时血清中和抗体效价仍维持在1∶1048以上,攻毒结果显示3个时间点强毒攻击后,免疫组所有动物白细胞数量都没有下降也没有分离到病毒,而对照组动物白细胞数下降均超过30%,6和9个月动物均分离到病毒,而12个月对照组动物由于年龄大,没有分离到病毒,因此暂定此疫苗的免疫持续期为9个月。     

Production and characterization of monoclonal antibodies against excretory-secretory products of Fasciola hepatica.

Four monoclonal antibodies (mAbs) (9.49, 24.27, 46.71 and 179.57) were produced against Fasciola hepatica excretory-secretory products. Isotype analysis revelead the antibodies to be IgM, IgG₃, IgG₁, and IgM. In immunoblot assays, the mAbs recognized different antigenic polypeptides migrating between 29 and 180 kDa. Specificity of the mAbs was evaluated by ELISA against antigens of Fascioloides magna, Anoplocephala magna, Stichorchis subtriquetrus, Haemonchus contortus, sheep liver extract (SLE), bovine liver extract (BLE), bovine serum albumin (BSA), bovine viral diarrhea virus (BVDV), and Madin-Darby bovine kidney (MDBK) cells. Monoclonals 9.49 and 24.27 were specific, and reacted only with Fasciola hepatica antigens. However, mAb 46.71 cross-reacted with antigens of Fascioloides magna, A. magna, Stichorchis subtriquetrus, and H. contortus but not with SLE, BLE, BSA, BVDV or MDBK cells. Monoclonal antibody 179.57 cross-reacted with Fascioloides magna, A. magna, S. subtriquetrus, H. contortus, SLE, and BLE, but not with BSA, BVDV, or MDBK cells.     

猪瘟疫苗中牛病毒性腹泻病毒2型的检测

为对上海某猪场送检的一份猪瘟疫苗进行牛病毒性腹泻病毒(BVDV)检测,本研究将猪瘟疫苗样品接种于MDBK细胞,盲传15代后仍无致细胞病变效应,但间接免疫荧光试验表明接种该疫苗后的MDBK细胞能够被单克隆抗体BZ-53(BVDV-2)识别。采用BVDV-1和BVDV-2的5’-UTR的通用检测引物和针对BVDV E2的引物,对样品RNA进行RT-PCR检测,结果显示,样品能够扩增出约288 bp的BVDV特异性片段;此外,5’-UTR和E2基因片段的测序分析结果表明分离株属于BVDV-2,并且其E2基因与牛源XJ-04株(BVDV-2)的E2基因同源性最高(92.3%),而与猪源ZM-95株(BVDV-1)的E2基因同源性较低(64.5%)。由此证明,该猪瘟疫苗中的确污染有一株BVDV-2株。     

In vitro permissivity of bovine peripheral blood mononuclear cells to bovine viral diarrhoea virus is dependent on the animal specific immune status

The in vitro permissivity to infection with homologous and heterologous bovine viral diarrhoea virus (BVDV) strains of bovine peripheral blood mononuclear cells (PBMCs) from eight na?ve and eight BVDV-1b immune animals was studied. Four reference strains (BVDV-1a NADL, BVDV-1b NY-1, BVDV-2 125 and BVDV-2 890) were selected, based on genotype, prevalence and biotype. Virus neutralizing antibody titres were determined at bleeding and the viral loads were measured in PBMCs by end point titration in cell culture and by real-time PCR. PBMCs from both na?ve and immune animals became infected by all BVDV strains tested, although virus titres were lower for immune heifers than na?ve ones; the differences were significant for NADL (P<0.05) and 890 (P<0.001) strains. The in vitro model used in this study showed that PBMCs from immune animals are susceptible to re-infection with both homologous and heterologous BVDV strains, albeit at a lower extent than na?ve cattle.     

河北省奶牛牛病毒性腹泻/粘膜病病毒的分离鉴定

从河北省某规模化奶牛场牛病毒性腹泻/粘膜病(BVD/MD)疑似病例中采集病料,将处理好的病料接种MDBK细胞,盲传9代,得到了不产生细胞病变的病毒。琼脂扩散试验表明本病毒能与牛病毒性腹泻病毒(BVDV)OregonC24标准阳性血清反应,出现沉淀线;细胞培养物用BVD/MD荧光抗体染色检测,可见到荧光着染的特异性细胞,荧光颗粒出现于胞浆中。双抗体夹心ELISA检测病毒抗原结果BVDVOregonC24VP/N为3.141,分离毒P/N为3.012,P/N>2,与BVDVOregonC24V结果一致;电镜观察到圆形、直径为40～60nm,有囊膜,囊膜表面有突起的病毒粒子,与BVDV颗粒基本一致。经RT-CR检测,扩增出了唯一的315bp的目的条带,进一步证实为牛病毒性腹泻/粘膜病病毒。     

牛病毒性腹泻病毒弱毒活疫苗免疫持续期的研究

为检测牛病毒性腹泻病毒(BVDV)弱毒活疫苗在免疫牛体内抗体产生及其消长规律,评价弱毒疫苗的保护效力,并确定免疫持续期,本试验对免疫试验牛每头颈部肌肉接种BVDV SM株弱毒疫苗104.5TCID50,监测血清抗体效价,进行免疫持续期的确定。在疫苗免疫后的6个月、9个月和12个月,分别抽取5头免疫组和5头对照组牛,采用BVDV-JL强毒株进行攻毒试验,每头牛攻毒剂量为6×107.0TCID50/mL。结果显示疫苗免疫后12个月时血清中和抗体效价仍维持在1∶1048以上。攻毒结果显示,在3个不同时间点进行强毒攻击后,免疫组所有动物白细胞数量都没有下降也没有分离到病毒,而对照组动物白细胞数下降均超过30%,6个月和9个月时动物血清中均能分离到病毒,而12个月对照组动物由于年龄大,没有分离到病毒,因此暂定此疫苗的免疫持续期为9个月。     

山西一例牛病毒性腹泻病例病原分离鉴定及测序分析

为查找引起山西某牛场疑似牛病毒性腹泻病例的病因,对送检的9份牛鼻腔棉拭子样品,经处理后进行了多病原PCR或RT-PCR检测、病原分离、特征性细胞病变观察、效价测定、RT-PCR鉴定及基因测序分析。结果显示:从9份样品中检出6份BVDV核酸阳性,IBRV、BRSV、BPIV3、支原体均阴性,病料上清接种MDBK细胞进行培养,传至F5代发现MDBK细胞出现特征性病变,表现为细胞变亮、圆缩、拉网并逐渐形成空泡,效价为10-5.42TCID50/0.1mL,BVDV RT-PCR鉴定阳性,将其命名为BVDV-SX2020株,测序发现其5’UTR与BVDV Oregon C24V等参考毒株同属BVDV基因1a亚型。结果证实该起病例由BVDV-1a毒株感染引起。     

牛病毒性腹泻-黏膜病病毒分离鉴定及生物学特性研究

为分离鉴定新疆地区牛病毒性腹泻-黏膜病病毒(BVDV)流行毒株,掌握该毒株的生物学特性,本试验在新疆北疆部分地区采集牛病毒性腹泻-黏膜病(BVD/MD)疑似病例的粪便,通过RT-PCR检测、细胞分离培养、间接免疫荧光抗体检测、免疫电镜观察及血清中和试验5种方法对毒株进行分离和鉴定。对毒株的TCID₅₀测定后,再对毒株分别进行乙醚敏感性试验、氯仿敏感性试验、胰蛋白酶敏感性试验、酸碱度敏感性试验、温度敏感性试验及核酸分型试验等理化特性检测。经RT-PCR诊断,病料在286 bp处出现了目的片段。将RT-PCR诊断为阳性的粪便,接种于密度约为80%的单层MDBK细胞出现了细胞病变,盲传5代至出现典型的细胞病变。将F5代细胞培养物采用间接免疫荧光抗体检测,结果产生了与C₂₄V标准毒株相同的特异性黄绿色荧光。免疫电镜观察到了大量呈球形的BVDV粒子,大小20~40 nm。血清中和试验中抗体阳性血清处理组细胞均未出现细胞病变,病毒完全被抗体阳性血清中和。综合以上方法确定分离株为BVDV毒株。对分离株进行毒价和理化特性测定,该毒株TCID₅₀为10^-4.5/0.1 mL,对乙醚和氯仿敏感,对胰蛋白酶敏感,耐碱不耐酸,对温度敏感,经54 ℃ 1 h完全被灭活,属于RNA病毒。本试验成功分离到一株新疆BVDV流行毒株,掌握了该毒株的生物学特性,为今后该病的诊断和防控奠定了基础。     

Production and characterization of monoclonal antibodies against excretory-secretory products of Fasciola hepatica

Four monoclonal antibodies (mAbs) (9.49, 24.27, 46.71 and 179.57) were produced against Fasciola hepatica excretory-secretory products. Isotype analysis revelead the antibodies to be IgM, IgG₃, IgG₁, and IgM. In immunoblot assays, the mAbs recognized different antigenic polypeptides migrating between 29 and 180 kDa. Specificity of the mAbs was evaluated by ELISA against antigens of Fascioloides magna, Anoplocephala magna, Stichorchis subtriquetrus, Haemonchus contortus, sheep liver extract (SLE), bovine liver extract (BLE), bovine serum albumin (BSA), bovine viral diarrhea virus (BVDV), and Madin-Darby bovine kidney (MDBK) cells. Monoclonals 9.49 and 24.27 were specific, and reacted only with Fasciola hepatica antigens. However, mAb 46.71 cross-reacted with antigens of Fascioloides magna, A. magna, Stichorchis subtriquetrus, and H. contortus but not with SLE, BLE, BSA, BVDV or MDBK cells. Monoclonal antibody 179.57 cross-reacted with Fascioloides magna, A. magna, S. subtriquetrus, H. contortus, SLE, and BLE, but not with BSA, BVDV, or MDBK cells.     

Humoral and T cell-mediated immune responses to bivalent killed bovine viral diarrhea virus vaccine in beef cattle

The objective of this research project was to evaluate the antibody and cell-mediated immune responses to a multivalent vaccine containing killed bovine viral diarrhea virus (BVDV) types 1 and 2. Twenty castrated male crossbred beef cattle (350-420kg body weight) seronegative to BVDV were randomly divided into two groups of 10 each. Group 1 served as negative mock-vaccinated control. Group 2 was vaccinated subcutaneously twice, 3 weeks apart, with modified live bovine herpesvirus 1, parainfluenza 3 virus and bovine respiratory syncytial virus diluted in diluent containing killed BVDV type 1 (strain 5960) and type 2 (strain 53637) in an adjuvant containing Quil A, Amphigen, and cholesterol. Serum samples were collected from all cattle at days -21, 0, and days 21, 28, 35, 56 and 70 post-vaccination. Standard serum virus neutralization tests were performed with BVDV type 1 (strain 5960) and type 2 (strain 125C). Anticoagulated blood samples were collected at day 0, and days 28, 35, 56 and 70 post-vaccination. Peripheral blood mononuclear cells (PBMCs) were isolated, stimulated with live BVDV type 1 (strain TGAN) and type 2 (strain 890) and cultured in vitro for 4 days. Supernatants of cultured cells were collected and saved for interferon gamma (IFNgamma) indirect enzyme-linked immunosorbent assay (ELISA). Four-color flow cytometry was performed to stain and identify cultured PBMC for three T cell surface markers (CD4, CD8, and gammadelta TCR) and to detect the activation marker CD25 (alpha chain of IL-2 receptor) expression. The net increase in %CD25+ cells (Delta%CD25+) of each T cell subset of individual cattle was calculated. The results of all post-vaccination weeks of each animal were plotted and the areas under the curve of each T cell subset were statistically analyzed and compared between groups. The mean area under the curve of the Delta%CD25+ data for days 0-70 of all subsets, except CD4-CD8+gammadelta TCR- (cytotoxic) T cell subset of both BVDV types 1 and 2 stimulated cells, of the vaccinated group were significantly higher than the control group (P<0.05). IFNgamma production by PBMC from the vaccinated group showed significantly higher results (P<0.05) than the control group in the BVDV types 1 and 2 stimulated cells for at least some time points after vaccination. The vaccinated group also had significantly (P<0.0001) higher neutralizing antibody titers than the control group from day 28 onward.     

Recombinant polypeptide from the gp48 region of the bovine viral diarrhea virus (BVDV) detects serum antibodies in vaccinated and infected cattle.

To characterize the immune response of cattle to bovine viral diarrhea virus (BVDV) glycoprotein gp48, we have produced a large amount of recombinant glutathione-s-transferase-gp48 (GST-gp48) fusion protein in Escherichia coli. Antibodies to gp48 were present in cattle vaccinated with killed or modified-live virus vaccination, or following natural infection. These results were in agreement with results of serum neutralization (SN) test which detected gp53 of BVDV.     

Identification of herds with cattle persistently infected with bovine viral diarrhea virus by virological evaluation of three calves

For the identification of herds with cattle persistently infected (PI) with bovine viral diarrhea virus, 1,272 animals from 20 herds were subjected to serum neutralizing (SN) test using the Nose strain and virus isolation. Eighteen PI cattle were detected from 5 herds. On the phylogenetic tree based on the nucleotide sequences of the 5' untranslated region, the isolates from the PI cattle were classified into genotypes-1a or -1b. Of 3 unvaccinated calves aged 6 to 12 months selected from each herd, the probabilities of obtaining 2 or more non-PI cattle with SN antibody titers of 64 or more (P(SN)), one or more PI cattle (P(VI)), and either of the conditions (P(Total)) were calculated using the hypergeometric probability model. P(Total) for the 5 herds with PI cattle was 1.000. P(SN) for 3 herds with many PI cattle within the selected age group was as low as 0.500 or less, and P(VI) was as high as 0.886 or more. P(SN) in the 2 other herds with few PI cattle was 1.000, and P(VI) was as low as 0.375 or less. P(Total) in 13 of 15 herds without PI cattle was 0.000, and was 0.714 or 0.774 for the 2 other herds. These results suggest that herds with PI cattle can be predicted with high accuracy when both SN test and virus isolation are performed on only 3 unvaccinated calves aged 6 to 12 months selected from a herd.     

猪源牛病毒性腹泻病毒JLS-01株的分离鉴定及致病性研究

为了解猪源牛病毒性腹泻病毒(bovine viral diarrhea virus,BVDV)的分子特征及致病性,本研究利用RT-PCR从吉林省某猪场出现严重腹泻症状的仔猪病料中检测到BVDV核酸阳性,将处理后的BVDV阳性样品接种于MDBK细胞,分离到1株病毒,命名为BVDV JLS-01。通过免疫荧光检测、5′UTR与Npro RT-PCR扩增对其分子进化特征进行分析。结果显示,该分离毒株在MDBK细胞上盲传至8代未出现细胞病变,在免疫荧光试验中呈阳性荧光信号。RT-PCR扩增获得大小分别为280和735bp的5′UTR和Npro片段。BVDV JLS-01株5′UTR与Npro序列遗传进化分析表明,其与LN-1和ZM-95亲缘性最近,与牛源毒株LN-1基因同源性达99.3%,提示该毒株可能来源于牛源毒株。将BVDV JLS-01株F8代细胞培养液人工感染BVDV和猪瘟病毒(CSFV)抗体阴性猪,感染猪未表现出明显的体温升高,但白细胞数量下降,并在感染猪的白细胞提取物中分离到该毒株,表明该毒株具有一定的致病性。该毒株的成功分离对进一步开展BVDV流行病学调查及致病机理等方面的研究具有重要意义。